Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Christopher L. Lotz, certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Qualigen Therapeutics, Inc., a Delaware corporation, for the year ended December 31, 2022; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
July 7, 2023 | By: | /s/ Christopher L. Lotz |
Name: | Christopher L. Lotz | |
Title: | Chief Financial Officer (Principal Financial Officer) |